<?xml version="1.0" encoding="UTF-8"?>	<item><status>past</status><description>&lt;p&gt;&lt;span style="color : #5a3291"&gt;&lt;strong&gt;May 22nd 2012: Medical Affairs, Clinical, Regulatory, Career Paths&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;span&gt;&lt;strong&gt;Location:&lt;/strong&gt;Massbio Offices, 300 Technology Square, 8th Floor, Cambridge MA 02139&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;span&gt;&lt;strong&gt;Time:&lt;/strong&gt; 5:30-8:00pm&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;span&gt;&lt;strong&gt;Moderator:&lt;/strong&gt;&lt;/span&gt; Laurie Halloran, President and CEO, Halloran Consulting Group&lt;/p&gt;
&lt;p&gt;&lt;span&gt;&lt;strong&gt;Panelists:&lt;/strong&gt;&lt;/span&gt; Eric Silberstein, CEO, TrialNetworks; &lt;span&gt;Joanne Lager MD, Project Head for PI3K Inhibitors, Sanofi Oncology; Shawna Cullen, PhD, Clinical Trial Head - Oncology Translational Medicine,&lt;/span&gt; Novartis Institutes for BioMedical Research, Inc.&lt;/p&gt;
&lt;p&gt;Â &lt;/p&gt;
&lt;p&gt;To register: &lt;a target="_blank" style="color : #5a3291 ; text-decoration : underline"&gt;http://fils52012.eventbrite.com/&lt;/a&gt;&lt;/p&gt;</description><event_hosts><event_hosts_item><member_name>Joshua Lang</member_name><member_id>3926861</member_id></event_hosts_item></event_hosts><maybe_rsvp_count>0</maybe_rsvp_count><waitlist_count>0</waitlist_count><updated>1337781469000</updated><rating><average>4.0</average><count>1</count></rating><group><who>Scientific Members</who><join_mode>open</join_mode><urlname>nexusproject</urlname><id>1294865</id><group_lat>42.3699989319</group_lat><group_lon>-71.0999984741</group_lon><name>Nexus Project</name></group><yes_rsvp_count>2</yes_rsvp_count><created>1336180192000</created><visibility>public</visibility><name>May 22nd 2012: Medical Affairs, Clinical, Regulatory, Career Paths</name><id>63488412</id><headcount>0</headcount><utc_offset>-14400000</utc_offset><time>1337722200000</time><event_url>http://www.meetup.com/nexusproject/events/63488412/</event_url></item>